The importance of COX-2 inhibition for aspirin induced asthma.
نویسنده
چکیده
There have been recent reviews of aspirin induced asthma (AIA), 2 the use of the COX-2 preferential inhibitor nimesulide in asthmatic patients intolerant to non-steroidal anti-inflammatory drugs (NSAIDs), and of nimesulide in general. 5 This paper discusses the importance of inhibiting prostaglandin E2 (PGE2) synthesis in AIA, and the relative safety of NSAIDs that preferentially inhibit COX-2. Aspirin and other NSAIDs cause bronchoconstriction in about 10% of asthmatic subjects but NSAIDs relieve asthma in about 0.3%. This variability helps to show the complexity of the problem. Prostaglandins in human lung are formed by various tissues and cells, including bronchial muscle, epithelium, and inflammatory cells, 2 so the inhibition of prostaglandin formation can have numerous eVects. In addition, the prostanoids (prostaglandins and thromboxanes) formed have different, and sometimes opposite, eVects on the lungs. Furthermore, NSAIDs may alter the synthesis of various prostaglandins diVerently in patients with AIA—for example, aspirin reduces the synthesis of PGE2 but not of the bronchoconstrictors PGD2 and PGF2á. 6 Inhibition of PGE2 synthesis seems to be particularly important in AIA for several reasons: PGE2 can relax bronchial muscle, inhibit the formation or release of various bronchoconstrictor agents such as leukotrienes and histamine (levels of which are raised in patients with AIA), and PGE2 administered as an aerosol inhibits aspirin induced bronchoconstriction. 2 Since PGE2 and other prostanoids are formed by both constitutive COX-1 and induced COX-2, the eVect on the lung may partly reflect the relative activities of each NSAID on the enzymes. Generally, in various tissues and organs such as the gastrointestinal mucosa and kidney, COX-1 produces prostaglandins that have physiological protective roles, whereas COX-2 induced at sites of inflammation forms prostaglandins that contribute to the disease. It is generally agreed that blocking COX-1 can damage the stomach and kidneys, at least when other factors are involved, and perhaps this applies to the lungs.
منابع مشابه
Unusual effects of aspirin on ticlopidine induced thrombolysis.
For hundreds of years salicylates have been used to treat fever and pain. Following the discovery that aspirin inhibits the biosynthesis of prostanoids, particularly thromboxane A2 (TXA2) in blood platelets, aspirin gained a new clinical indication as an antiplatelet and antithrombotic drug. Aspirin acetylates the serine 529 residue of cyclo-oxygenase 1 (COX-1) in platelets and megakaryocytes; ...
متن کاملCOX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease
The use of analgesic anti-inflammatory agents in patients with asthma is clinically challenging because of the prevalence (10-20%) of aspirin hypersensitivity. Aspirin-exacerbated respiratory disease (AERD), or aspirin-induced asthma, is characterized by asthma and rhinitis triggered by the ingestion of aspirin and non-steroidal anti-inflammatory drugs. AERD is associated with upper and lower r...
متن کاملToo many COX (cyclo-oxygenase) spoil the broth: aspirin-sensitive asthma and 5-lypoxygenase.
10 as a hypothesis driven article. Nevertheless, at the time it in the current issue of Thorax confirms that COX-2 is was thought to be too controversial and unsubstantiated present in asthmatic tissue. Why then are NSAIDs un-by any scientific evidence. However, with the publication successful in the treatment of asthmatic symptoms? More-by the journal of Sousa's work showing that COX-2 is over...
متن کاملNew tests for tuberculosis: local immune responses have greater specificity.
Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects. Expression of interleukin-5 and granulocyte-macrophage ...
متن کاملاثر مهار آنزیم سیکلواکسیژناز-2 بر سفتی عضلانی مدل حیوانی بیماری پارکینسون
Background: Parkinson's disease (PD) is a degenerative neurodopaminergic disease in nigrostriatum pathway of animals and human, the resultant loss of nerve terminals accompanied by dopamine-glutamate and other related neurotransmitters-imbalances in this pathway are responsible for most of the movement abnormalities. Increasing evidence suggests that an inflammatory reaction accompanies the pat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Thorax
دوره 55 Suppl 2 شماره
صفحات -
تاریخ انتشار 2000